⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL668534 | 0.97 | CES2 (0.50) | — | |
| SCHEMBL27943933 | 0.97 | CES2 (0.50) | — | |
| SCHEMBL27383124 | 0.97 | CES2 (0.50) | — | |
| Hydrochloric Acid SCHEMBL27128353 | 0.97 | CES2 (0.43) | — | |
| SCHEMBL27944970 | 0.95 | CES2 (0.48) | — | |
| Hydrochloric Acid SCHEMBL12099257 | 0.95 | CES2 (0.48) | — | |
| Hydrochloric Acid SCHEMBL28392169 | 0.95 | CES2 (0.48) | — | |
| SCHEMBL27925808 | 0.95 | CES2 (0.48) | — | |
| SCHEMBL668274 | 0.94 | — | — | |
| SCHEMBL24684871 | 0.88 | KMT2A (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105412640-A | Medicine composition for treating cervical ectropion and preparing method thereof | ZHANG YUN | 2016-03-23 | — | — | CN | claimed |
| CN-105327282-A | Medicine composition for treating gynecological uterine cervicitis and preparing method thereof | SUN XIULIAN | 2016-02-17 | — | — | CN | claimed |
| US-20250000942-A1 | PEPTIDES AND METHODS OF TRANSPLANTATION AND RESTORATIVE ORGAN FUNCTION | PRINCE BIOTECH, LLC | 2025-01-02 | — | — | US | disclosed |
| CN-114269367-A | Therapeutic peptides | 科巴公司 | 2022-04-01 | — | — | CN | disclosed |
| CN-113518784-A | Therapeutic peptides | 科巴公司 | 2021-10-19 | — | — | CN | disclosed |
| CN-110352068-A | The immunity receptor and its application method of synthesis | 南加利福尼亚大学 | 2019-10-18 | — | — | CN | disclosed |
| CN-110072883-A | The relevant peptide of therapeutic MOTS-C | 科巴公司 | 2019-07-30 | — | — | CN | disclosed |
| US-10196428-B2 | Modification of cupredoxin derived peptides | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2019-02-05 | — | — | US | disclosed |
| US-10149896-B2 | MHC-I restricted epitopes containing non-natural amino acid residues | PURDUE PHARMA L.P. (US) | 2018-12-11 | — | — | US | disclosed |
| US-20170319670-A1 | MHC-I Restricted Epitopes Containing Non-Natural Amino Acid Residues | PURDUE PHARMA L.P. (US) | 2017-11-09 | — | — | US | disclosed |
| US-20170174729-A1 | MODIFICATION OF CUPREDOXIN DERIVED PEPTIDES AND METHODS OF USE THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2017-06-22 | — | — | US | disclosed |
| WO-2005098435-A2 | PEPTIDES AND PEPTIDOMIMETICS BINDING TO CD23 | UNIVERSITE BORDEAUX 2 (FR) | 2005-10-20 | — | — | WO | disclosed |
| EP-1250340-B1 | METHODS AND COMPOUNDS FOR INHIBITING MRP1 | LILLY CO ELI (US) | 2004-11-17 | — | — | EP | disclosed |
| US-20040176405-A1 | Methods and compounds for inhibitting MRP1 | KROIN JULIAN (US) | 2004-09-09 | — | — | US | disclosed |
| US-6743794-B2 | MULTIDRUG RESISTANCE PROTEIN; CANCER; 3-(9-CHLORO-3-METHYL-4-OXO-5H-ISOXAZOLO(4,3-C)QUINOLIN-5-YL)) CYCLOHEXYL)-2-PIPERIDYLACETAMIDE | ELI LILLY AND COMPANY | 2004-06-01 | — | — | US | disclosed |
| US-20030100576-A1 | Methods and compounds for inhibiting mrp1 | ELI LILLY AND COMPANY | 2003-05-29 | — | — | US | disclosed |
| EP-1250340-A1 | METHODS AND COMPOUNDS FOR INHIBITING MRP1 | ELI LILLY AND COMPANY (US) | 2002-10-23 | — | — | EP | disclosed |
| EP-1147078-A1 | ACETYLENIC (BETA)-SULFONAMIDO AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS | American Cyanamid Company (US) | 2001-10-24 | — | — | EP | disclosed |
| WO-2001046199-A1 | METHODS AND COMPOUNDS FOR INHIBITING MRP1 | ELI LILLY AND COMPANY (US) | 2001-06-28 | — | — | WO | disclosed |
| WO-2000044711-A1 | ACETYLENIC $G(b)-SULFONAMIDO AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 2000-08-03 | — | — | WO | disclosed |